Lv7
3560 积分 2023-08-17 加入
YLT192, a Novel, Orally Active Bioavailable Inhibitor of VEGFR2 Signaling with Potent Antiangiogenic Activity and Antitumor Efficacy in Preclinical Models
3天前
已完结
YLT192, a Novel, Orally Active Bioavailable Inhibitor of VEGFR2 Signaling with Potent Antiangiogenic Activity and Antitumor Efficacy in Preclinical Models
3天前
已完结
Discovery of novel thiophene-3-carboxamide derivatives as potential VEGFR-2 inhibitors with anti-angiogenic properties
3天前
已完结
Typhae Pollen active subfraction exerts antiangiogenic effect in benign prostatic hyperplasia via regulating the VEGF signaling pathway and arachidonic acid metabolism
5天前
已完结
Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel anti-angiogenesis agent
5天前
已完结
CD44-mediated metabolic rewiring is a targetable dependency of IDH-mutant leukemia
5天前
已完结
Typhae Pollen active subfraction exerts antiangiogenic effect in benign prostatic hyperplasia via regulating the VEGF signaling pathway and arachidonic acid metabolism
22天前
已完结
Stem cell–homing biomimetic hydrogel promotes the repair of osteoporotic bone defects through osteogenic and angiogenic coupling
22天前
已完结
Engineering selective PI3Kγ inhibitors with antitumor and immunomodulatory potentials
24天前
已完结
Engineering selective PI3Kγ inhibitors with antitumor and immunomodulatory potentials
29天前
已完结
皖公网安备34019202002308
